The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease
نویسندگان
چکیده
531. Results of a Hepatitis C Virus Screening Program of the 1945-1965 Birth Cohort in a Large Emergency Department in New Jersey Julia Kang Cornett, MD; Vimal Bodiwala, MD; Victor Razuk, BS; Devangi Shukla, BS, MBS and Navaneeth Narayanan, Pharm D, BCPS; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, Department of Pharmacy Practice and Administration, Rutgers Ernest Mario School of Pharmacy, Piscataway, New Jersey
منابع مشابه
New treatment of hepatitis C (Direct Acting Antiviral)
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for the patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, and because of developments in diagnostic procedures and improvements in therapy an...
متن کاملHepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review
Hepatocellular carcinoma (HCC) is a leading cause of liver-related death worldwide. Hepatitis C virus (HCV) infection is a major cause of advanced hepatic fibrosis and cirrhosis, with significantly increased risk for development of HCC. The morbidity and mortality of HCV-related HCC remains high, as rates of HCV cirrhosis continue to increase. The long-term goal of antiviral therapy for chronic...
متن کاملSuccessful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
Hepatitis C virus (HCV) infection is frequently associated with various extrahepatic manifestations, such as autoimmune features and immune complex deposit diseases. Oral lichen planus (OLP) is one such extrahepatic manifestation of HCV infection. Recently, direct-acting antivirals (DAA) have proved to be highly effective and safe for the eradication of HCV. Herein, we report a case of OLP acco...
متن کاملAccelerated hepatocellular carcinoma recurrence rate after postoperative direct-acting antivirals treatment – preliminary report
Aim of the study New interferon-free direct-acting antiviral (DAA) therapy has led to major progress in hepatitis C virus (HCV) treatment. Current outcomes are promising, especially in compensated cirrhosis. However, there are reports of accelerated hepatocellular carcinoma (HCC) recurrence after surgery in patients treated with DAAs. The influence of DAA therapy on the timing and frequency of ...
متن کاملThe New Era of Interferon-Free Treatment of Chronic Hepatitis C
BACKGROUND Within the development and approval of several new direct-acting antivirals (DAA) against hepatitis C virus (HCV), a new era of hepatitis C therapy has begun. Even more treatment options are likely to become available during the next 1-2 years. METHODS A summary of the current phase II and III trials investigating DAA and a review of the recent HCV guidelines was conducted. RESUL...
متن کامل